With a passion for innovating technology and a clear understanding of business dynamics, Qbic supports researchers and entrepreneurs in transforming technological breakthroughs into successful companies.
"We want to contribute to transforming agriculture into something sustainable."
Aphea.Bio is developing the next generation of agricultural biologicals.
Blue Foot Membranes
Blue Foot Membranes provides water-intensive industries with the technology to reuse water.
"The aim is to have one of the most prominent photonics hubs in Europe, and even globally, located in Ghent."
Sentea leverages silicon photonics to develop a cost-effective fiber optic sensor interrogator.
"When it comes to battery-powered low energy sensing, Aloxy should be the go-to company for the petrochemical industry worldwide."
Aloxy’s Internet of Things technology is enabling the petrochemical industry to innovate.
Aquatic Science produces chemical-free biological filtration systems for pools and ponds.
iFLUX directly monitors the speed and direction of groundwater contamination spreading in time.
EyeD Pharma is developing micro-implants for controlled release of one or more drugs over a prolonged period of time.
"There was no equipment on the market to manufacture implants at a micrometer dimension, so we built it ourselves."
UniD Manufacturing is a contract development and manufacturing company of micro-implants.
Calltic developed an acoustic analysis method allowing to quickly and accurately detect telecom fraud.
"MicroLED displays could take out all the currently available display types. It would be great if QustomDot could facilitate this.”
QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications.
MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.
"Managing diabetes should be as easy as possible, and that is what we want to help accomplish."
Indigo is developing an implantable sensor that allows to continuously measure glucose and other metabolites for up to two years.
ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.
Accelleran provides OpenRAN Software solutions for operators of 5G networks.
"As the first-ever digital health app to be reimbursed in Belgium, we are setting the standard for healthcare’s transition to value-based (digital) care."
moveUP develops data-driven personalized remote digital care for patients undergoing surgery and other interventions.
CrowdScan provides accurate and privacy-friendly crowd measurement data.
Biotalys is developing a new generation of protein-based biocontrol solutions.
Acquired by Agilent Technologies.